BeBetter Med Inc. (SHA:688759)
39.61
-0.69 (-1.71%)
At close: Apr 16, 2026
BeBetter Med Statistics
Total Valuation
BeBetter Med has a market cap or net worth of CNY 17.83 billion. The enterprise value is 17.71 billion.
| Market Cap | 17.83B |
| Enterprise Value | 17.71B |
Important Dates
The next estimated earnings date is Friday, April 24, 2026.
| Earnings Date | Apr 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BeBetter Med has 450.04 million shares outstanding.
| Current Share Class | 450.04M |
| Shares Outstanding | 450.04M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +22.96% |
| Owned by Insiders (%) | 50.03% |
| Owned by Institutions (%) | 18.55% |
| Float | 178.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 82.78 |
| P/TBV Ratio | 100.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -115.66 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BeBetter Med has paid 189,500 in taxes.
| Income Tax | 189,500 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 40.14 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 50.87 |
| Average Volume (20 Days) | 3,406,128 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -152.89M |
| Pretax Income | -152.89M |
| Net Income | -153.08M |
| EBITDA | n/a |
| EBIT | -152.89M |
| Earnings Per Share (EPS) | -0.40 |
Balance Sheet
The company has 120.73 million in cash and 151,826 in debt, with a net cash position of 120.58 million or 0.27 per share.
| Cash & Cash Equivalents | 120.73M |
| Total Debt | 151,826 |
| Net Cash | 120.58M |
| Net Cash Per Share | 0.27 |
| Equity (Book Value) | 215.35M |
| Book Value Per Share | 0.60 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BeBetter Med does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -0.86% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |